Additive effect of unoprostone and latanoprost in patients with elevated intraocular pressure

British Journal of Ophthalmology

Volumn 86, Issue 1, 2002, Pages 75-79

  Aung, Tin ^a   Chew, Paul T K ^a,b   Oen, Francis T S ^a   Chan, Yiong Huak ^c   Thean, Lennard H ^a   Yip, Leonard ^a   Lim, Boon Ang ^a   Seah, Steve K L ^a  

^a SINGAPORE NATIONAL EYE CENTRE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c Clinical Trials and Epidemiology Research Unit   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

LATANOPROST; UNOPROSTONE ISOPROPYL ESTER;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG POTENTIATION; DRUG TOLERABILITY; EYE IRRITATION; FEMALE; HUMAN; HYPEREMIA; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MALE; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; DINOPROST; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OCULAR HYPERTENSION; PROSPECTIVE STUDIES; PROSTAGLANDINS F, SYNTHETIC;

EID: 0036148932     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.86.1.75     Document Type: Article

References (31)

1. Latanoprost administered once daily caused a maintained reduction of intraocular pressure in glaucoma patients treated concomitantly with timolol
2. Effects on intraocular pressure and side effects of 0.005% latanoprost once daily, evening and morning. A comparison with timolol
3. Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma. A six-month, masked, multicenter trial in the United States
4. A six month randomized double-masked study comparing latanoprost to timolol in open angle glaucoma and ocular hypertension
5. A comparison of latanoprost and timolol in primary open-angle glaucoma and ocular hypertension. A 12-week study
6. Latanoprost, a prostaglandin analog, for glaucoma treatment. Efficacy and safety after one year of treatment in 198 patients
7. Latanoprost-two years' experience of its use in the United Kingdom
8. 2α analogue on aqueous humour dynamics in human eyes
9. 2α analogue, after topical application in normal and ocular hypertensive human eyes
10. Double masked comparative study of UF-021 and timolol ophthalmic solutions in patients with primary open angle glaucoma or ocular hypertension
11. Long term study of UF-021 ophthalmic solution in patients with primary open angle glaucoma or ocular hypertension
12. Clinical evaluation of UF-021 ophthalmic solution in glaucoma patients refractory to maximum tolerable therapy
13. Ocular hypotensive mechanism of topical isopropyl unoprostone, a novel prostaglandin metabolite-related drug in rabbits
14. Ocular hypotensive effects and mechanisms of prostaglandin-related drugs
15. Latanoprost administered once daily caused a maintained reduction of intraocular pressure in glaucoma patients treated concomitantly with timolol
16. 26 analogue, and timolol in patients with elevated intraocular pressure
17. Interaction of PhXA41, a new prostaglandin analogue with pilocarpine
18. The additive intraocular pressure-lowering effect of latanoprost 0.005% once daily and pilocarpine 2% tid in patients with open-angle glaucoma or ocular hypertension, a six-month randomized multicenter study
19. The additive intraocular pressure-lowering effect of latanoprost in combined therapy with other ocular hypotensive agents
20. Additive effect of latanoprost and dorzolamide in patients with elevated intraocular pressure
21. The additive ocular hypotensive effect of latanoprost and acetazolamide. A short-term study in patients with elevated intraocular pressure
22. Additive effect of latanoprost to the combination of timolol and dorzolamide
23. Additive efficacy of unoprostone isopropyl 0.12% (Rescula) to latanoprost 0.005%
24. A clinical evaluation of UF-021, a new prostaglandin-related compound, in low-tension glaucoma patients
25. Reduction of intraocular pressure with treatment of latanoprost once daily in patients with normal-pressure glaucoma
26. The effect of once-daily latanoprost on intraocular pressure and pulsatile ocular blood flow in normal tension glaucoma
27. Intraocular pressure lowering effects of latanoprost monotherapy versus latanoprost or pilocarpine in combination with timolol: A randomised, observer masked multicenter study in patients with open angle glaucoma
28. The effects of prostaglandin F2 in the human eye
29. Cystoid macular edema and anterior uveitis associated with latanoprost use
30. Anterior uveitis associated with latanoprost